Max Healthcare

Max Healthcare slips 20% in 3 weeks, stock hits over 2-year low; here's why

Max Healthcare share price: In the past three days, the stock price of the hospital company slipped 7% on reports that the government plans to extend the 30% price caps to non-scheduled cancer drugs.

Pharmacy margin cap may lead to tariff recalibration: Max Healthcare MD

Max Healthcare's Abhay Soi discusses the economics of hospital care, regulatory scrutiny of medicine mark-ups and reforms needed to improve affordability and expand healthcare capacity

Hospital stocks: Why have Fortis, Apollo, Max, Yatharth rallied up to 5%?

According to reports, the Centre has decided to cap trade margins for all non-scheduled anti-cancer drugs at 30 per cent of the MRP.

At 52-week lows: RIL, ONGC, M&M, Airtel, PB Fintech, 69 other BSE500 stocks

The foreign institutional investors remained net sellers for the fifth consecutive session, offloading equities worth more than ₹10,148 crore on Wednesday, September 30, 2026.

Delhi Master Plan 2047 puts brokerages' spotlight on Max, Fortis, Medanta

For hospital operators, a Jefferies note said the MPD introduces several measures that could improve asset productivity and enable higher capacity creation in land-constrained areas.

Hospital stocks trade weak: Max Healthcare, Fortis, Apollo fall up to 7%

At 2 PM on Wednesday, the BSE Hospital index was the top loser among sectoral indices, down 3 per cent, compared to a 0.77 per cent decline in the BSE Sensex.

India's hospital chains grow bigger even as expansion squeezes margins: EY

Rising occupancies, more complex treatments and steady patient volumes are driving growth across hospitals and diagnostics. The next challenge is managing costs while adding thousands of new beds

After Max, Fortis enters Odisha with 300-bed super-speciality hospital

Fortis Healthcare will set up its first major project in Odisha through a 300-bed super-speciality hospital in Cuttack under an operations and management pact with Dion Group

Motilal Oswal sector of the week: Healthcare; Max, Global Health top picks

Indian healthcare sector remains well positioned for sustained long-term growth, supported by structural demand, expanding hospital infra, higher healthcare spends, and favourable demographic trends.

Strong fundamentals drive hospital stocks rally in 2026; check top picks

Analysts say that the market is rewarding hospital companies not merely as defensive plays, but as scalable consumption businesses with strong pricing power, rising cash flows & long growth visibility

Max Healthcare falls 7% on Q4 results; profit rises 7% amid margin pressure

Max Healthcare reported a consolidated revenue from operations of ₹2,142.89 crore, up 12.2 per cent from ₹1,909.74 crore in the year-ago period

Stocks to watch today: ITC, Maruti Suzuki, Nykaa, LIC, LG Electronics

Stocks to Watch today, May 22, 2026: Nykaa, LIC, ITC, Honasa Consumer, and Maruti Suzuki are some of the key stocks to watch today

Max Healthcare Q4 PAT rises 7.2%, revenue rises 12% on occupancy

Max Healthcare reported a 7.2 per cent rise in fourth-quarter profit and 12 per cent revenue growth, aided by higher occupancy and international patient demand

Max Healthcare Institute Q4FY26 network PAT rises 3% to ₹387 crore

Max Healthcare Institute Ltd on Thursday reported a 3 per cent increase in network profit after tax to Rs 387 crore in the fourth quarter ended March 31, 2026. The company, which had posted a network profit after tax (PAT) of Rs 376 crore in the corresponding quarter previous fiscal, said its board has approved an investment of Rs 1,400 crore for construction of a 712-bed greenfield hospital at Shaheed Path, Lucknow. Gross revenue in the fourth quarter stood at Rs 2,664 crore, a growth of 10 per cent over the same period of the previous fiscal, Max Healthcare Institute Ltd said in a statement. Bed occupancy for the quarter was at 75 per cent, with occupied bed days (OBDs) up by 8 per cent YoY, while ARPOB (average revenue per occupied bed) for Q4 FY26 stood at Rs 77,900 compared to Rs 77,100 in Q4 FY25, the company said. The board of directors has recommended a final dividend of Rs 2 per equity share of face value of Rs 10 for 2025-26, it added. For the financial year ended March

Improving mix, volumes seen driving growth recovery for Max Healthcare

Brokerages remain positive on Max Healthcare despite recent weakness, expecting growth revival in FY27 led by expansion, better occupancy, improved mix and strong margins

Max Healthcare to add 1,200 beds in FY27, says Chairman Abhay Soi

Max Healthcare plans to expand capacity to 6,500 beds by FY27 and boost medical tourism through overseas offices and new facilities, including a 400-bed tower in Delhi

Pharma cos brace for soft Q4; US drag persists; domestic growth cushions

Pharma sector may see a 7 per cent Y-o-Y growth in reported sales and a 1 per cent increase in Ebitda, led by steady ex-gRevlimid US sales, healthy domestic growth, and favourable forex movements

Max Healthcare acquires 58.4% stake in Kalinga Hospital for ₹300 crore

Max Healthcare enters eastern India with Kalinga Hospital acquisition, adding 250 beds and expanding its network through a Rs 300 crore deal

Equirus Sec prefers Apollo, KIMS as hospital sector growth accelerates

Equirus Securities reckon that healthcare sector delivered a 15.5 per cent revenue CAGR and a 25 per cent Ebitda CAGR between FY20 and FY25

Iran war impact: Emkay sees Nifty at 21,000; lists top 3 stocks to buy now

Emkay Global warns of a 10-per cent downside in Nifty as Iran war volatility keeps crude oil above $100 per barrel. It has picked HDFC Bank, Eternal, and Max Healthcare as top stocks to buy now.